Aetna Inc. (NYSE:AET) President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the completion of the sale, the president now owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of Aetna Inc. (NYSE:AET) traded down 0.86% during trading on Thursday, hitting $153.69. The company’s stock had a trading volume of 459,467 shares. The company has a market capitalization of $51.04 billion, a P/E ratio of 34.12 and a beta of 0.53. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $164.52. The firm’s 50 day moving average is $157.50 and its 200-day moving average is $145.70.

Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, beating the Zacks’ consensus estimate of $2.34 by $1.08. The business had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.21 EPS. Analysts forecast that Aetna Inc. will post $9.55 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was first reported by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://www.watchlistnews.com/aetna-inc-aet-president-karen-s-lynch-sells-15271-shares-of-stock/1578661.html.

Several hedge funds and other institutional investors have recently modified their holdings of AET. BlackRock Inc. increased its holdings in shares of Aetna by 3,374.9% during the 1st quarter. BlackRock Inc. now owns 30,712,219 shares of the company’s stock valued at $3,917,344,000 after acquiring an additional 29,828,390 shares during the last quarter. FMR LLC boosted its stake in Aetna by 73.8% during the 2nd quarter. FMR LLC now owns 13,736,800 shares of the company’s stock valued at $2,085,659,000 after purchasing an additional 5,833,567 shares during the period. Janus Henderson Group PLC boosted its stake in Aetna by 9,446.2% during the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock valued at $657,255,000 after purchasing an additional 4,283,553 shares during the period. Capital World Investors boosted its stake in Aetna by 8.9% during the 2nd quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock valued at $3,153,358,000 after purchasing an additional 1,688,767 shares during the period. Finally, Vanguard Group Inc. boosted its stake in Aetna by 3.8% during the 1st quarter. Vanguard Group Inc. now owns 23,117,526 shares of the company’s stock valued at $2,948,640,000 after purchasing an additional 838,578 shares during the period. 89.52% of the stock is currently owned by institutional investors and hedge funds.

A number of brokerages have recently issued reports on AET. Royal Bank Of Canada boosted their target price on Aetna from $147.00 to $162.00 and gave the stock an “outperform” rating in a report on Friday, June 9th. BidaskClub cut Aetna from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Deutsche Bank AG boosted their target price on Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a report on Monday, August 7th. Morgan Stanley began coverage on Aetna in a report on Tuesday, June 6th. They set an “overweight” rating and a $162.00 target price for the company. Finally, Argus reiterated a “buy” rating and set a $165.00 target price (up previously from $145.00) on shares of Aetna in a report on Tuesday, May 30th. Seven equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. The company has an average rating of “Buy” and an average target price of $159.04.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.